【LYC 0075 交流专区】(前名 MEXTER)

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "COMPANY")PROPOSED DISPOSAL OF 80% EQUITY INTEREST IN MEXCOMM SDN BHD ("MEXCOMM"), A SUBSIDIARY OF MEXTER TO CHAN WAI FONG FOR A CASH CONSIDERATION OF RM187,727.20 ("PROPOSED DISPOSAL")
(For consistency, the abbreviations used throughout this announcement shall have the same meanings as defined in the earlier announcement(s), where applicable, unless stated otherwise or defined herein.) Reference is made to the Company’s announcement dated 7 September 2018 in relation to the Proposed Disposal (“Announcement”). On behalf of the Board of Directors of the Company, Public Investment Bank Berhad is pleased to furnish herewith additional information pertaining to the Announcement: (i)      the utilisation of proceeds from the repayment of the Debt and the expected timeframe for utilisation of the proceeds. The proceeds from the repayment of the Debt shall be utilised for working capital requirements of the Group and is expected to be utilised within twelve (12) months from the date of receipt of each installments. (ii)      the length of time the SPS is made available for inspection. A copy of the SPA is available for inspection at the registered office of the Company at Lot 6.05, Level 6, KPMG Tower, 8 First Avenue, Bandar Utama, 47800 Petaling Jaya, Selangor Darul Ehsan, from Mondays to Fridays (excluding public holidays) during normal office hours for a period of three (3) months from the date of the Announcement. This announcement is dated 13 September 2018.

icy97

Name	LYC CAPITAL SDN BHD
Address	F-2-10, Block F, Plaza Damas, No. 60, Jalan Sri Hartamas 1 Kuala Lumpur 50480 Wilayah Persekutuan Malaysia.
Company No.	1083157-V
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	07 Sep 2018	6,221,000	Others	Direct Interest
	Name of registered holder	LYC Capital Sdn Bhd
	Address of registered holder	F-2-10, Block F, Plaza Damas, No. 60, Jalan Sri Hartamas 1 50480 Kuala Lumpur
	Description of "Others" Type of Transaction	Warrants Conversion

Circumstances by reason of which change has occurred	Conversion of warrants to ordinary shares
Nature of interest	Direct Interest
Direct (units)	64,406,400
Direct (%)	20.164
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	64,406,400
Date of notice	13 Sep 2018
Date notice received by Listed Issuer	13 Sep 2018

icy97

MEXTER TECHNOLOGY BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Exercise of Warrants
Details of corporate proposal	Conversion of Warrant "A"
No. of shares issued under this corporate proposal	5,445,500
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.1300
Par Value($$) (if applicable)	Malaysian Ringgit (MYR)
Latest issued share capital after the above corporate proposal in the following
Units	324,864,340
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 44,916,931.000
Listing Date	21 Sep 2018

icy97

Type	Announcement
Subject	OTHERS
Description	MEXTER TECHNOLOGY BERHAD (MEXTER OR THE COMPANY)SERVICE AND COLLABORATION AGREEMENT ENTERED BETWEEN LYC MEDICARE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF MEXTER TECHNOLOGY BERHAD AND UNIVERSITY MALAYA MEDICAL CENTRE (UMMC), VIA UNIVERSITY MALAYA (UM)  (COLLECTIVELY REFERRED AS PARTIES)
1.0 INTRODUCTION The Board of Directors of Mexter (“Board”) wishes to announce that LYC Medicare Sdn Bhd (Company No. 680188-M) (herein referred to as “LYCM”), a wholly-owned subsidiary of the Company had on 1 October 2018 entered into a Service and Collaboration Agreement (“Agreement”) with UMMC via UM, a university established under the Universities and University Colleges Act 1971 and having its registered address at Lembah Pantai, 59100, Kuala Lumpur to establish a brand namely “LYC Fertility Centre” in collaboration with UM brand, to promote, develop, and market UMMC’s fertility and other medical services. Based on the Agreement, the parties have agreed to collaborate with each other to market UMMC’s fertility and other medical services via LYCM’s establishment of “LYC Fertility Centre”, a service provider to cater for high-end fertility patients and also to promote medical tourism for international patients. 2.0 INFORMATION OF UMMC UMMC was incorporated on 5th August 1968 to serve the three main areas of teaching, research and service. It is under jurisdiction of University of Malaya statute since 25th May 2000 and it is one of the organizations in the Ministry of Higher Education. 3.0 SALIENT TERMS OF THE AGREEMENT 3.1    Scope LYCM shall act as a service provider for the value added non-clinical functions for the patients of LYC Fertility Centre while UMMC will provide the medical related services. LYCM will leverage on the operational and medical excellence of UMMC’s fertility treatment division and market its services by establishing a premium category of service under the branding of LYC Fertility Centre to potential customers seeking treatments for infertility. 3.2    Duration The Agreement shall be effective as of the execution date of the Agreement and shall be for a period of five (5) years unless terminated earlier with an option to extend of an additional five (5) years, subject to fulfilment of certain performance based requirements. 4.0 RATIONALE FOR THE AGREEMENT The Agreement is in line with the Company’s current business direction and strategy to increase the revenue and profits contribution from the healthcare services business segment. With the commencement of the Company’s postpartum care business under LYC Mother & Child Centre Sdn Bhd at Plaza VADS, Taman Tun Dr Ismail, the Company believes the establishment of LYC Fertility Centre will allow it to generate business synergies by referral of potential customers upon successful fertility treatments. The Agreement will also be beneficial to UMMC as it is able to attract fertility patients which are seeking premium services and also to promote medical tourism for international patients. It is expected that the Agreement will also help boost UMMC’s profile in the international market. 5.0 THE RISK IN RELATION TO THE AGREEMENT The risks are the general risks encountered by other companies undertaking a similar endeavor and the Company has taken the necessary steps to protect itself and to mitigate the risks as and when it occurs. 6.0 FINANCIAL EFFECTS This Agreement will not have any material impact on the total share capital of the Company and the earnings and net assets of the Group for the financial year ending 31 March 2019. 7.0 APPROVAL REQUIRED This Agreement is not subject to the approval of shareholders and any other relevant authorities. 8.0 DIRECTORS AND MAJOR SHAREHOLDERS’ INTEREST None of the Directors and/or Major Shareholders of the Company and/or persons connected to them, have any interest, direct or indirect, in the Agreement 9.0 DIRECTORS’ STATEMENT The Board of the Company, having taken into consideration all terms and conditions of the Agreement, is of the opinion that the Agreement is in the best interest of the Company. This announcement is dated 1 October 2018

icy97

Type	Announcement
Subject	OTHERS
Description	MEXTER TECHNOLOGY BERHAD ("MEXTER" OR THE "COMPANY") - INCORPORATION OF A SUBSIDIARY COMPANY
1. Introduction Pursuant to Rule 9.19(23) of Bursa Malaysia Securities Berhad ACE Market Listing Requirements, the Board of Directors of MEXTER wishes to announce that the Company has on 19 October 2018 incorporated a 70 % owned subsidiary known as LYC Living Sdn Bhd (Company No. 1300403-D) ("LYCL"). The remaining 30% shareholding is held by Mr Soh Hoo Hong (“Mr Soh”). 2. Information of LYCL LYCL was incorporated as a private limited company by shares. The share capital of LYCL is RM1,000.00 comprising 1,000 ordinary shares. The intended principal activities of LYCL are to provide all services related to lifestyle, wellness, health, healthcare and medicine in particular but not limited to the provision of consultancy, advice, sales and marketing, intellectual property, management, training, recruitment, care, hospital / medical centre / senior living home designs, setting up and operations or any other form of related service or services thereto. 3. Financial Effect of the Incorporation of LYCL The incorporation of LYCL does not have any effect on the share capital and substantial shareholders’ shareholdings of MEXTER. It is also not expected to have any material effect on the net assets, gearing and earnings of MEXTER for the financial year ending 31 March 2019. 4. Directors’ and Major Shareholders’ Interests None of the Directors or major shareholders of MEXTER or persons connected with them, have any direct or indirect interest in the incorporation of LYCL. This announcement is dated 22 October 2018.

icy97

icy97 发表于 13-6-2018 01:37 AM

Type	Announcement
Subject	OTHERS
Description	MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "THE COMPANY")SHAREHOLDER AGREEMENT ENTERED BETWEEN THE COMPANY AND ASIAVEST INVESTMENTS PTE. LTD. AND SUBSCRIPTION OF ADDITIONAL ORDINARY SHARES IN THE SHARE CAPITAL OF LYC SENIOR LIVING SDN BHD
Reference is made to the announcement of the Company on 5 June 2018, in relation to the incorporation of a wholly-owned subsidiary known as LYC Senior Living Sdn Bhd (Company No. 1282603-P) ("LYCSL"). The Board of Directors of MEXTER wishes to announce that the Company had on 26 October 2018 entered into a Shareholder Agreement with Asiavest Investments Pte. Ltd. (Company No. 201822984W) (“Asiavest”) (“Shareholder Agreement”) to formalize and set out the basic terms of their relationship with each other and via their respective investment and participation in the business of LYCSL. Kindly refer to the attached announcement on the Shareholder Agreement entered between the Company and Asiavest . This announcement is dated 26 October 2018.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5956173

Attachments Shareholder Agreement with Asiavest Investments 26.10.2018.pdf

icy97

icy97 发表于 8-9-2018 06:03 AM
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5909417

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "COMPANY")PROPOSED DISPOSAL OF 80% EQUITY INTEREST IN MEXCOMM SDN BHD ("MEXCOMM"), A SUBSIDIARY OF MEXTER TO CHAN WAI FONG FOR A CASH CONSIDERATION OF RM187,727.20 ("PROPOSED DISPOSAL")
(For consistency, the abbreviations used throughout this announcement shall have the same meanings as defined in the earlier announcement(s), where applicable, unless stated otherwise or defined herein.) Reference is made to the Company’s announcement made on 7 September 2018. On behalf of the Board of Directors of Mexter, Public Investment Bank Berhad wishes to announce that the Proposed Disposal has been completed on 30 October 2018 upon the completion of all requisite security documents in accordance to the terms of the SPA. This announcement is dated 30 October 2018.

icy97

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "COMPANY")(I)        PROPOSED DIVERSIFICATION;(II)        PROPOSED CONSULTANCY AND PM AGREEMENT;(III)        PROPOSED SHAREHOLDERS AGREEMENT;(IV)        PROPOSED AMENDMENT TO THE CONSTITUTION; AND(V)        PROPOSED CHANGE OF COMPANY NAME,(COLLECTIVELY REFERRED TO AS THE "PROPOSALS").
On behalf of the Board of Directors of Mexter (“Board”), Public Investment Bank Berhad (“PIVB”) wishes to announce the following: (i)         proposed diversification of the business of Mexter and its subsidiaries (“Group”) to include the following: (a)        provision of consultancy and project management services for the development, construction and sale of integrated healthcare and wellness development, including but not limited to age proof living, medical tourism hotel and residence, medical and dental centre, physiotherapy and chiropractor, childcare and nursery, and wellness facilities (“Wellness Related Hub”); (b)        healthcare service provider, including but not limited to managing and operating the Wellness Related Hub; and (c)        provision of retirement home and aged care facilities and services, (collectively referred as “Proposed Diversification”). (ii)        LYC Living Sdn Bhd, a 70% owned subsidiary of Mexter (“LYC Living”) had on 30 October 2018 entered into a conditional consultancy and project management agreement with LYC Venture Sdn Bhd (“Consultancy and PM Agreement”) for the provision of general consultancy, advise and project management to facilitate the construction, sale and development of a piece of ten (10) acres 99 year leasehold land held under and known as H.S.(D) 16194, No. PT 20362, Mukim Bentong, Daerah Bentong, Negeri Pahang into a medical, healthcare related and wellness community provisionally known as LYC Wellness Valley (“Project Services”) (“Proposed Consultancy and PM Agreement”); (iii)       Mexter had on 30 October 2018 entered into a shareholders agreement (“Shareholders Agreement”) with Mr. Soh Hoo Hong, an existing shareholder of LYC Living, to facilitate the provision of the Project Services as well as to govern the relationship between Mexter and Mr. Soh as the shareholders of LYC Living (“Proposed Shareholders Agreement”); (iv)       proposed amendment to the constitution of Mexter (“Constitution”) to facilitate the Proposed Diversification (“Proposed Amendment to the Constitution”); and (v)        proposed change of name from Mexter Technology Berhad to LYC Healthcare Berhad (“Proposed Change of Company Name”), (collectively referred as “Proposals”). The full text of this announcement pertaining to the Proposals is attached herein. This announcement is dated 30 October 2018.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5959813

Attachments Mexter Technology Berhad - Announcement_30Oct2018.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "COMPANY")PROPOSED DISPOSAL OF 80% EQUITY INTEREST IN MEXCOMM SDN BHD ("MEXCOMM"), A SUBSIDIARY OF MEXTER TO CHAN WAI FONG FOR A CASH CONSIDERATION OF RM187,727.20 ("PROPOSED DISPOSAL") - CESSATION OF SUBSIDIARIES OF MEXTER
References are made to the Company’s announcements made on 7 September 2018 and 30 October 2018 in relation to the Proposed Disposal of 80% equity interest in Mexcomm. The Board of Directors of MEXTER wishes to announce that following the completion of the Proposed Disposal on 30 October 2018, the following companies have ceased to be subsidiaries of Mexter (“Cessation”):- (i) Mexcomm Sdn Bhd (ii) Ezymobile International Sdn Bhd (iii) Mobile Holding Ltd. (iv) Ezy M Holding Ltd. (v) E-G6 Solution (Thailand) Co. Ltd. (vi) P.T. Mexcomm The above Cessation has no material financial and operational impact on Mexter for the financial year ending 31 March 2019. None of the Directors, substantial shareholders of Mexter or persons connected to them has any interest, direct or indirect, in the Cessation. This announcement is dated 31 October 2018.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2018	30 Sep 2017	30 Sep 2018	30 Sep 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	5,662	4,800	10,406	9,109
2	Profit/(loss) before tax	-1,465	-833	-3,051	-1,902
3	Profit/(loss) for the period	-1,463	-831	-3,047	-1,898
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,588	-686	-3,072	-1,611
5	Basic earnings/(loss) per share (Subunit)	-0.49	-0.31	-1.03	-0.75
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0800		0.0800

icy97

MEXTER - CHANGE OF NAME FROM MEXTER TECHNOLOGY BERHAD TO LYC HEALTHCARE BERHAD

MEXTER TECHNOLOGY BERHAD

Kindly be advised that the aforesaid Company has changed its name to "LYC HEALTHCARE BERHAD​”. As such, the Company's shares will be traded and quoted under the new name with effect from 9.00 a.m., Tuesday, 22 January 2019, as follows:

Old Name	Old Stock Short Name	New Name	New Stock Short Name
MEXTER TECHNOLOGY BERHAD	MEXTER	LYC HEALTHCARE BERHAD	LYC

The Stock Number remains unchanged.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2018	31 Dec 2017	31 Dec 2018	31 Dec 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,807	1,681	5,133	5,163
2	Profit/(loss) before tax	-2,200	-862	-5,287	-1,825
3	Profit/(loss) for the period	-514	-1,058	-3,597	-2,956
4	Profit/(loss) attributable to ordinary equity holders of the parent	-520	-999	-3,628	-2,610
5	Basic earnings/(loss) per share (Subunit)	-0.16	-0.41	-1.22	-1.18
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0800		0.0800

icy97

Type	Announcement
Subject	OTHERS
Description	LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - INCORPORATION OF A SUBSIDIARY COMPANY
1. Introduction Pursuant to Rule 9.19(23) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of LYC wishes to announce that the Company has on 30 April 2019 incorporated a Fifty-One percent (51%) owned subsidiary known as LYC Cosmetic & Aesthetic Sdn Bhd (Company No. 1324708-T) ("LYCCA"). The remaining Forty-Nine percent (49%) shareholding is held by Xing Dao International Pte. Ltd. (Company No. 201801391W)(“Xing Dao”). 2. Information of LYCCA LYCCA was incorporated on 30 April 2019 as a private limited company by shares in Malaysia under the Companies Act, 2016. The share capital of LYCCA as at the date of announcement is Ringgit Malaysia One Hundred Only (RM100.00) comprising One Hundred (100) ordinary shares. LYC holds Fifty-One (51) shares for Ringgit Malaysia Fifty-One only (RM51.00), representing 51% shareholding of LYCCA while Xing Dao holds Forty-Nine (49) shares for Ringgit Malaysia Forty-Nine only (RM49.00), representing 49% shareholding of LYCCA. The intended principal activities of LYCCA are to carry on the business of cosmetics, personal care, wellness related products and services and medical aesthetic treatment. The current directors of LYCCA are Mr Sui Diong Hoe and Dr Zhao Yingli (“Dr Zhao”). 3. Information of Xing Dao Xing Dao is an exempt private limited company by shares in Singapore and is wholly owned by Dr Zhao. The issued share capital of Xing Dao is Singapore Dollars One Hundred Thousand only (SGD100,000) comprising One Hundred Thousand (100,000) ordinary shares. Dr Zhao is the sole director of Xing Dao. 4. Information of Dr Zhao Dr Zhao is the founder of one of the first private cosmetic and aesthetic medical centres in China, Zhi Yin Cosmetic & Aesthetic Medical Centre, Beijing. Zhi Yin Cosmetic & Aesthetic Medical Centre is a leading pioneer in cosmetic and aesthetic healthcare industry in China, serving thousands of Chinese patients which have benefited from the well-trained team of cosmetic and aesthetic doctors, led by Dr Zhao. 5. Rationale The Company will look to leverage on Dr Zhao’s extensive track record in the cosmetic and aesthetic field and the Company’s healthcare and marketing expertise to drive the business of LYCCA. The incorporation is also in line with the Company’s plans to further diversify its business in the healthcare space, with a focus on medical tourism. 6. Financial Effect of the Incorporation of LYCCA The incorporation of LYCCA does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYC for the financial year ending 31 March 2020. 7. Directors’ and Major Shareholders’ Interests None of the Directors and/or major shareholders of LYC or persons connected with them, have any direct or indirect interest in the incorporation of LYCCA. This announcement is dated 30 April 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6148445

Attachments Press Release-Incorporation of LYC Cosmetic and Aesthetic Sdn Bhd.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	LYC HEALTHCARE BERHAD (COMPANY NO. 647673-A)("LYC" OR "THE COMPANY")PROPOSAL TO SET-UP OF A SIXTY-EIGHT (68) BEDROOM POSTPARTUM CARE CENTRE AT AURORA PLACE @ BUKIT JALIL, KUALA LUMPUR ("LYCM BUKIT JALIL CENTRE")
The Board of Directors of the LYC wishes to announce that LYC Mother & Child Centre Sdn Bhd (Company No. 972687-K) (“LYCM”) , a wholly-owned subsidiary of the Company had on 30 April 2019 entered into a Tenancy Agreement with Ho Hup Jaya Sdn Bhd (Company No. 82449-V) (“Ho Hup Jaya”) for the rental of one (1) retail unit lot at Aurora SOVO and three (3) retail unit lots at Ho Hup Tower to set-up a postpartum care centre to serve the surrounding neighborhood. Kindly refer to the attached announcement on the proposed set up of LYCM Bukit Jalil Centre . This announcement is dated 30 April 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6148453

Attachments Announcement - Proposed Set Up of Third LYCM Centre in Bukit Jalil.pdf Press Release - Proposed Set Up of Third LYCM Child Centre in Bukit Jalil.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2019	31 Mar 2018	31 Mar 2019	31 Mar 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	2,470	1,248	7,603	6,411
2	Profit/(loss) before tax	-2,238	-1,471	-7,525	-3,296
3	Profit/(loss) for the period	-2,300	-2,514	-5,897	-5,470
4	Profit/(loss) attributable to ordinary equity holders of the parent	-2,253	-2,570	-5,881	-5,180
5	Basic earnings/(loss) per share (Subunit)	-0.69	-1.00	-1.97	-2.31
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0700		0.0800

icy97

lyc保健冀私配筹1040万
https://www.enanyang.my/news/20190810/lyc保健冀私配筹1040万/

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	LYC HEALTHCARE BERHAD ("LYC" OR "COMPANY")PROPOSED PRIVATE PLACEMENT OF UP TO 32,486,400 NEW ORDINARY SHARES IN LYC ("LYC SHARE(S)" OR "SHARE(S)"), REPRESENTING APPROXIMATELY TEN PERCENT (10%) OF THE TOTAL NUMBER OF ISSUED SHARES OF LYC ("PROPOSED PRIVATE PLACEMENT")
On behalf of the Board of Directors of LYC, Alliance Investment Bank Berhad wishes to announce that the Company proposes to undertake the Proposed Private Placement. Further details of the Proposed Private Placement are set out in the attachment. This announcement is dated 5 August 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6244773

Attachments BursaLINK (Initial Announcement) - Attachment.pdf

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	LYC HEALTHCARE BERHAD ("LYC" OR "COMPANY") PROPOSED PRIVATE PLACEMENT OF UP TO 32,486,400 NEW ORDINARY SHARES IN LYC ("LYC SHARE(S)" OR "SHARE(S)"), REPRESENTING APPROXIMATELY TEN PERCENT (10%) OF THE TOTAL NUMBER OF ISSUED SHARES OF LYC ("PROPOSED PRIVATE PLACEMENT")
(Unless otherwise defined, defined terms used in this announcement shall carry the same meanings as defined in the announcement dated 5 August 2019 in relation to the Proposed Private Placement ("Announcement")) We refer to the Announcement in relation to the Proposed Private Placement. On behalf of the Board of Directors of LYC, Alliance Investment Bank Berhad wishes to announce additional information in relation to the Proposed Private Placement as set out in the attachment enclosed. This announcement is dated 14 August 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6252793

Attachments LYC - Additional announcement.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2019	30 Jun 2018	30 Jun 2019	30 Jun 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	2,686	4,744	2,686	4,744
2	Profit/(loss) before tax	-1,592	-1,589	-1,592	-1,589
3	Profit/(loss) for the period	-1,590	-1,587	-1,590	-1,587
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,543	-1,488	-1,543	-1,488
5	Basic earnings/(loss) per share (Subunit)	-0.47	-0.57	-0.47	-0.57
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0700		0.0700

icy97

LYC HEALTHCARE BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	Placement Shares issued pursuant to the Proposed Private Placement
No. of shares issued under this corporate proposal	8,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.3000
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	332,864,340
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 61,615,404.480
Listing Date	25 Sep 2019

icy97

Type	Announcement
Subject	OTHERS
Description	LYC HEALTHCARE BERHAD (COMPANY NO. 647673-A)("LYC" OR "THE COMPANY")PROPOSAL TO SET-UP A COSMETIC & AESTHETIC CENTRE AT WISMA LIFE CARE IN JALAN KERINCHI, BANGSAR SOUTH, KUALA LUMPUR ("LYCCA BANGSAR SOUTH CENTRE")
The Board of Directors of LYC wishes to announce that LYC Cosmetic & Aesthetics Sdn Bhd (Company No. 1324708-T)(“LYCCA”), a fifty-one percent (51%) owned subsidiary of the Company, had on 4 October 2019 entered into a Tenancy Agreement with Ong Care Scan Sdn Bhd (Company No. 692430-W) for the rental of one (1) retail unit lot at Wisma Life Care to set-up a cosmetic and aesthetic business to cater for both local and international patients. Kindly refer to the attached announcement on the proposed set up of LYCCA Bangsar South Centre. This announcement is dated 4 October 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6302709

Attachments Announcement - Proposal to Set-up LYCCA Centre at Wisma Life Care.pdf